| scholarly article | Q13442814 |
| P50 | author | Julie M Mhlaba | Q57004346 |
| P2093 | author name string | I Caroline Le Poole | |
| Roopal V Kundu | |||
| Stephanie M Rangel | |||
| P2860 | cites work | Diet in dermatology: Revisited | Q22305448 |
| Genetic epidemiology of vitiligo: multilocus recessivity cross-validated | Q24672700 | ||
| 'VIT1', a novel gene associated with vitiligo | Q24678481 | ||
| Specification of the neural crest occurs during gastrulation and requires Pax7 | Q28239511 | ||
| Monobenzone-induced depigmentation: from enzymatic blockade to autoimmunity | Q28241227 | ||
| High frequency of cephalic neural crest cells shows coexistence of neurogenic, melanogenic, and osteogenic differentiation capacities | Q28752647 | ||
| Genetics of Vitiligo | Q30235209 | ||
| Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo | Q30881976 | ||
| Chemical Leukoderma Associated with Methylphenidate Transdermal System: Data From the US Food and Drug Administration Adverse Event Reporting System | Q31136963 | ||
| A study of Q-switched Nd:YAG laser irradiation and paracrine function in human skin cells | Q31172521 | ||
| Low-energy helium-neon laser induces locomotion of the immature melanoblasts and promotes melanogenesis of the more differentiated melanoblasts: recapitulation of vitiligo repigmentation in vitro | Q33243183 | ||
| Vitiligo: a possible model of degenerative diseases | Q33355586 | ||
| CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin | Q33390838 | ||
| CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo | Q33864128 | ||
| A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat | Q33897820 | ||
| Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo. | Q34020057 | ||
| Stressful life events, social support, attachment security and alexithymia in vitiligo. A case-control study. | Q34192047 | ||
| Functional melanocytes are readily reprogrammable from multilineage-differentiating stress-enduring (muse) cells, distinct stem cells in human fibroblasts. | Q34337632 | ||
| A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? | Q34535453 | ||
| Rhododendrol, a depigmentation-inducing phenolic compound, exerts melanocyte cytotoxicity via a tyrosinase-dependent mechanism | Q34662172 | ||
| Dermal mesenchymal stem cells (DMSCs) inhibit skin-homing CD8+ T cell activity, a determining factor of vitiligo patients' autologous melanocytes transplantation efficiency | Q34663693 | ||
| Vitiligo: a manifestation of apoptosis? | Q34691252 | ||
| Multiple pathways to tumor immunity and concomitant autoimmunity | Q35005947 | ||
| Commensal bacteria and cutaneous immunity | Q35344600 | ||
| Association of Vitiligo and Alopecia Areata With Atopic Dermatitis: A Systematic Review and Meta-analysis. | Q35486510 | ||
| 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo | Q35537998 | ||
| Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis | Q35672638 | ||
| On the etiology of contact/occupational vitiligo | Q35771681 | ||
| Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. | Q35773559 | ||
| Microbial community profiling shows dysbiosis in the lesional skin of Vitiligo subjects | Q35892111 | ||
| Role of keratinocytes in the development of vitiligo | Q35942240 | ||
| Isolating RNA from precursor and mature melanocytes from human vitiligo and normal skin using laser capture microdissection | Q36021615 | ||
| Targeting iHSP 70 in vitiligo: a critical step for cure? | Q43793862 | ||
| Most individuals with either segmental or non-segmental vitiligo display evidence of bilateral cochlear dysfunction. | Q44030486 | ||
| Provoking factors, including chemicals, in Dutch patients with vitiligo | Q44071867 | ||
| Energetic mitochondrial failing in vitiligo and possible rescue by cardiolipin | Q45070729 | ||
| Relationship between Helicobacter pylori infection and vitiligo: a prospective study | Q45153169 | ||
| Involvement of superoxide dismutase isoenzymes and their genetic variants in progression of and higher susceptibility to vitiligo | Q45196019 | ||
| Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity | Q46312769 | ||
| Metabo-miR: miR-211 Regulates Mitochondrial Energy Metabolism in Vitiligo | Q46316008 | ||
| Reduced Nrf2 activation in PI3K phosphorylation-impaired vitiliginous keratinocytes increases susceptibility to ROS-generating chemical-induced apoptosis | Q46316983 | ||
| Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo | Q46457478 | ||
| Vitiligo: the historical curse of depigmentation | Q47286652 | ||
| Cessation of spread as a treatment objective in vitiligo: perception from the patients' point of view | Q47597459 | ||
| Glabrous lesional stem cells differentiated into functional melanocytes: new hope for repigmentation | Q47609020 | ||
| Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure. | Q47929993 | ||
| Vitiligo: Mechanistic insights lead to novel treatments | Q47989542 | ||
| The catalase gene promoter and 5'-untranslated region variants lead to altered gene expression and enzyme activity in vitiligo. | Q48100121 | ||
| PD-L1 reverses depigmentation in Pmel-1 vitiligo mice by increasing the abundance of Tregs in the skin. | Q48162560 | ||
| Dermatology life quality index scores in children with vitiligo: comparison with atopic dermatitis and healthy control subjects. | Q48203138 | ||
| The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone. | Q48333222 | ||
| Targeting CTLA-4, PD-L1 and IDO to modulate immune responses in vitiligo | Q49048342 | ||
| Replenishing Regulatory T Cells to Halt Depigmentation in Vitiligo | Q49895242 | ||
| Vitiligo Skin Is Imprinted with Resident Memory CD8 T Cells Expressing CXCR3. | Q50014282 | ||
| Initiation and regulation of CD8+T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo. | Q36023298 | ||
| Therapeutic implications of autoimmune vitiligo T cells. | Q36292745 | ||
| The Molecular Revolution in Cutaneous Biology: The Era of Genome-Wide Association Studies and Statistical, Big Data, and Computational Topics | Q36347686 | ||
| The role of IL-17 in vitiligo: A review | Q36625953 | ||
| Comparison of plasma malondialdehyde, glutathione, glutathione peroxidase, hydroxyproline and selenium levels in patients with vitiligo and healthy controls | Q37391617 | ||
| Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants | Q37432581 | ||
| Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets | Q37611016 | ||
| Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress | Q37626557 | ||
| Altered expression of four miRNA (miR-1238-3p, miR-202-3p, miR-630 and miR-766-3p) and their potential targets in peripheral blood from vitiligo patients. | Q38433669 | ||
| Association between vitiligo extent and distribution and quality-of-life impairment | Q38453409 | ||
| Herpesvirus connection in the expression of autoimmune vitiligo in Smyth line chickens | Q38457539 | ||
| Prevalence and Clinical Characteristics of Itch in Vitiligo and Its Clinical Significance. | Q38614872 | ||
| MicroRNA-211 Regulates Oxidative Phosphorylation and Energy Metabolism in Human Vitiligo | Q38703571 | ||
| Follicular vitiligo: A report of 8 cases | Q38718210 | ||
| Functional cloning of a gp100-reactive T-cell receptor from vitiligo patient skin | Q38798375 | ||
| The many faces of interleukin-17 in inflammatory skin diseases | Q38818542 | ||
| Immunohistochemical Analysis of GDNF and Its Cognate Receptor GFRα-1 Protein Expression in Vitiliginous Skin Lesions | Q38838204 | ||
| Immunohistochemical evaluation of vitiliginous hair follicle melanocyte reservoir: is it retained? | Q39178708 | ||
| Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8. | Q39331724 | ||
| Sequential immunohistochemical study of depigmenting and repigmenting minigrafts in vitiligo | Q39673690 | ||
| Resident memory T cells in the skin mediate durable immunity to melanoma. | Q40122403 | ||
| Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients | Q40282263 | ||
| Qualitative difference between the cytotoxic T lymphocyte responses to melanocyte antigens in melanoma and vitiligo. | Q40362128 | ||
| Incident alopecia areata and vitiligo in adult women with atopic dermatitis: Nurses' Health Study 2. | Q40373910 | ||
| Current update and trends in melanin pigmentation and melanin biology. | Q40531351 | ||
| Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo. | Q40647918 | ||
| Differentiation of murine melanocyte precursors induced by 1,25-dihydroxyvitamin D3 is associated with the stimulation of endothelin B receptor expression | Q40704328 | ||
| Review of the etiopathomechanism of vitiligo: a convergence theory | Q40742658 | ||
| Prevalence of Impaired Hearing and Vision in Patients with Vitiligo | Q40767582 | ||
| Molecular basis of congenital hypopigmentary disorders in humans: a review | Q41487071 | ||
| Mapping architectural and transcriptional alterations in non-lesional and lesional epidermis in vitiligo | Q41549820 | ||
| A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8⁺ T-cell accumulation in the skin | Q42145851 | ||
| Patterns of repigmentation in two cases of hypopigmented type of vitiligo | Q42171409 | ||
| Sunlight Effects on Immune System: Is There Something Else in addition to UV-Induced Immunosuppression? | Q42341616 | ||
| Maintenance of distinct melanocyte populations in the interfollicular epidermis | Q42380763 | ||
| Catecholamines increase in the urine of non-segmental vitiligo especially during its active phase | Q42437955 | ||
| Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo | Q42472166 | ||
| Immunolocalization of tenascin-C in vitiligo | Q42504755 | ||
| Histopathologic features in vitiligo | Q42526000 | ||
| Can systemically generated reactive oxygen species help to monitor disease activity in generalized vitiligo? A pilot study | Q43044634 | ||
| Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo | Q43116514 | ||
| Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease | Q43252679 | ||
| Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation | Q43298046 | ||
| Vitiligo Skin: Exploring the Dermal Compartment | Q50099530 | ||
| A failure in endothelin-1 production from vitiligo keratinocytes in response to ultraviolet B irradiation. | Q50866269 | ||
| Keratinocyte cultures from involved skin in vitiligo patients show an impaired in vitro behaviour. | Q50955818 | ||
| CXCR3 Depleting Antibodies Prevent and Reverse Vitiligo in Mice. | Q51167268 | ||
| Low-concentration hydrogen peroxide can upregulate keratinocyte intracellular calcium and PAR-2 expression in a human keratinocyte-melanocyte co-culture system. | Q51410860 | ||
| Photooxidation of Tryptophan and Tyrosine Residues in Human Serum Albumin Sensitized by Pterin: A Model for Globular Protein Photodamage in Skin. | Q51586281 | ||
| Expansion of vitiligo lesions is associated with reduced epidermal CDw60 expression and increased expression of HLA-DR in perilesional skin | Q51798314 | ||
| Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. | Q51799957 | ||
| An immunohistological study of cutaneous lymphocytes in vitiligo. | Q52062156 | ||
| Molecular analysis of vitiligo lesions reveals sporadic melanocyte survival. | Q53567027 | ||
| The role of VIT1/FBXO11 in the regulation of apoptosis and tyrosinase export from endoplasmic reticulum in cultured melanocytes. | Q54425876 | ||
| Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin. | Q54714854 | ||
| HLA-A2 Restricted, Melanocyte-Specific CD8+ T Lymphocytes Detected in Vitiligo Patients are Related to Disease Activity and are Predominantly Directed Against MelanA/MART1 | Q56795513 | ||
| New Insights into the Pathogenesis of Vitiligo: Imbalance of Epidermal Cytokines at Sites of Lesions | Q58798285 | ||
| Skin-Depigmenting Agent Monobenzone Induces Potent T-Cell Autoimmunity toward Pigmented Cells by Tyrosinase Haptenation and Melanosome Autophagy | Q60628789 | ||
| Genetic Association of the Catalase Gene (CAT) with Vitiligo Susceptibility | Q62660314 | ||
| Koebner phenomenon in vitiligo in an Indian population | Q62660368 | ||
| Treatment of refractory and stable vitiligo by transplantation of in vitro cultured epidermal autografts bearing melanocytes | Q68079831 | ||
| Cytolytic antibodies to melanocytes in vitiligo | Q70723942 | ||
| Presence or Absence of Melanocytes in Vitiligo Lesions: An Immunohistochemical Investigation | Q72081046 | ||
| Organotypic culture of human skin to study melanocyte migration | Q72156077 | ||
| The change of melanocyte cytotoxicity after systemic steroid treatment in vitiligo patients | Q72311630 | ||
| Probable mechanisms of loss of Merkel cells in completely depigmented skin of stable vitiligo | Q72352710 | ||
| Catechol-O-methyltransferase in vitiligo | Q72356152 | ||
| Immunohistochemical studies from vitiligo--comparison between active and inactive lesions | Q72581546 | ||
| A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders | Q72651347 | ||
| A role for a melanosome transport signal in accessing the MHC class II presentation pathway and in eliciting CD4+ T cell responses | Q73201937 | ||
| Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families | Q73406857 | ||
| Vitiligo and epidermal microenvironment: possible involvement of keratinocyte-derived cytokines | Q77636798 | ||
| Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay | Q77807077 | ||
| Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo | Q79736207 | ||
| VIT1 gene and vitiligo | Q80646271 | ||
| Stress in patients with alopecia areata and vitiligo | Q80689956 | ||
| Expressional changes in the intracellular melanogenesis pathways and their possible role in the pathogenesis of vitiligo | Q81364983 | ||
| Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir | Q82250068 | ||
| Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris | Q82780398 | ||
| Association of UVRAG polymorphisms with susceptibility to non-segmental vitiligo in a Korean sample | Q82936052 | ||
| The haptenation theory of vitiligo and melanoma rejection: a close-up | Q83262035 | ||
| Disseminated vitiligo developing around Kaposi sarcoma nodules in an AIDS patient | Q83313897 | ||
| Vitiligo exacerbated after herpes zoster | Q83573488 | ||
| Interleukin-33 affects cytokine production by keratinocytes in vitiligo | Q85633369 | ||
| Post-herpetic vitiligo in an 8-year-old boy with immunosuppression | Q87197725 | ||
| Genetic variations (Arg5Pro and Leu6Pro) modulate the structure and activity of GPX1 and genetic risk for vitiligo | Q87488232 | ||
| Distinct temperament and character profiles in first onset vitiligo but not in alopecia areata | Q87514729 | ||
| P433 | issue | 6 | |
| P921 | main subject | vitiligo | Q180152 |
| P304 | page(s) | 647-655 | |
| P577 | publication date | 2018-06-28 | |
| P1433 | published in | Experimental Dermatology | Q15749509 |
| P1476 | title | The convergence theory for vitiligo: A reappraisal | |
| P478 | volume | 28 |
| Q92029854 | Autoimmune diseases affecting skin melanocytes in dogs, cats and horses: vitiligo and the uveodermatological syndrome: a comprehensive review | cites work | P2860 |
Search more.